Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of<i>de novo</i>HLA donor-specific antibodies

Abstract

The findings suggest that higher levels of pretransplant circulating antibodies against AT1R (>30 U) in kidney graft recipients constitute an independent risk factor for earlier de novo HLA-DSA detection during the posttransplant period.